Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Total Debt (2023 - 2025)

Historic Total Debt for Perspective Therapeutics (CATX) over the last 3 years, with Q3 2025 value amounting to $1.6 million.

  • Perspective Therapeutics' Total Debt fell 335.78% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 335.78%. This contributed to the annual value of $1.6 million for FY2024, which is 304.3% down from last year.
  • Latest data reveals that Perspective Therapeutics reported Total Debt of $1.6 million as of Q3 2025, which was down 335.78% from $1.6 million recorded in Q2 2025.
  • Perspective Therapeutics' 5-year Total Debt high stood at $1.7 million for Q1 2023, and its period low was $1.6 million during Q3 2025.
  • Its 3-year average for Total Debt is $1.6 million, with a median of $1.7 million in 2024.
  • As far as peak fluctuations go, Perspective Therapeutics' Total Debt crashed by 291.89% in 2024, and later tumbled by 335.78% in 2025.
  • Perspective Therapeutics' Total Debt (Quarter) stood at $1.7 million in 2023, then fell by 3.04% to $1.6 million in 2024, then dropped by 2.58% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.6 million for Q2 2025, and $1.6 million during Q1 2025.